Elisa Redl

Innsbruck, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

Journal: NPJ breast cancer
Published: February 25, 2026

Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriers.

Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriers.

Journal: Communications medicine
Published: September 08, 2025

The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.

The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.

Journal: International journal of cancer
Published: August 05, 2025

Performance of the WID-qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana.

Performance of the WID-qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana.

Journal: International journal of cancer
Published: August 28, 2024

A validated HPLC-MS/MS method for the quantification of systemic mifepristone after subcutaneous application in mice.

A validated HPLC-MS/MS method for the quantification of systemic mifepristone after subcutaneous application in mice.

Journal: Analytical methods : advancing methods and applications
Published: July 24, 2024

Functionally enriched epigenetic clocks reveal tissue-specific discordant aging patterns in individuals with cancer.

Functionally enriched epigenetic clocks reveal tissue-specific discordant aging patterns in individuals with cancer.

Journal: Communications medicine
Published: July 11, 2024

Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures.

Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures.

Journal: Communications medicine
Published: April 30, 2024

High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalities.

High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalities.

Journal: International journal of cancer
Published: February 09, 2024

Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarrays.

Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarrays.

Journal: Clinical epigenetics
Published: February 08, 2024

Cervical cancer screening using DNA methylation triage in a real-world population.

Cervical cancer screening using DNA methylation triage in a real-world population.

Journal: Nature medicine
Published: January 19, 2024

Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK.

Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK.

Journal: The Lancet. Oncology
Published: July 20, 2023

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

Journal: Molecular cancer
Published: March 23, 2023
Showing 1-12 of 19

Last Updated: 09/26/2026